Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,834.00
-29.00 (-1.56%)
Oct 23, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 47.9 billion as of October 23, 2026. It is the 17,997th most valuable company in the world and the 1,379th biggest in Japan. Its market cap has increased by 22.31% in one year.
Market Cap
47.90B
Enterprise Value
66.85B
Revenue
60.11B
Global Rank
Country Rank
#1,379 Japan
PE Ratio
15.36
ChartMarket Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 47.90B, an increase of 175.56%. That is a compound annual growth rate of 4.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 47.90B | 3.75% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 157.85B |
| Kaken Pharmaceutical | 145.41B |
| Mochida Pharmaceutical | 115.38B |
| Zeria Pharmaceutical | 89.22B |
| KYORIN Pharmaceutical | 64.63B |
| ASKA Pharmaceutical Holdings | 56.96B |
| Daito Pharmaceutical | 37.59B |
| Koa Shoji Holdings | 34.62B |